Stock Analysis on Net

Humana Inc. (NYSE:HUM)

$22.49

This company has been moved to the archive! The financial data has not been updated since October 30, 2024.

Adjustments to Financial Statements

Microsoft Excel

Adjustments to Current Assets

Humana Inc., adjusted current assets

US$ in millions

Microsoft Excel
Dec 31, 2023 Dec 31, 2022 Dec 31, 2021 Dec 31, 2020 Dec 31, 2019
As Reported
Current assets
Adjustments
Add: Allowance for doubtful accounts
After Adjustment
Adjusted current assets

Based on: 10-K (reporting date: 2023-12-31), 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31).


The financial data for the period from 2019 to 2023 indicates a consistent upward trend in current assets and adjusted current assets. Both metrics exhibited steady growth year over year without any declines or irregular fluctuations.

Current Assets
Current assets increased from $19,888 million in 2019 to $29,986 million in 2023. This represents a robust growth over five years, with particularly notable increments each year, reflecting enhanced liquidity and asset accumulation.
Adjusted Current Assets
Adjusted current assets closely mirror the pattern observed in current assets, rising from $19,957 million in 2019 to $30,074 million in 2023. The slight difference between current assets and adjusted current assets suggests consistent adjustments, but the overall growth trajectory remains strongly positive.

The data suggests an improvement in the company’s short-term financial position, with increasing resources available to meet current liabilities. The parallel growth of both current and adjusted current assets implies sound asset management and a favorable liquidity profile over the analyzed timeframe.


Adjustments to Total Assets

Humana Inc., adjusted total assets

US$ in millions

Microsoft Excel
Dec 31, 2023 Dec 31, 2022 Dec 31, 2021 Dec 31, 2020 Dec 31, 2019
As Reported
Total assets
Adjustments
Add: Operating lease right-of-use asset (before adoption of FASB Topic 842)1
Add: Allowance for doubtful accounts
Less: Deferred income tax assets (classified as Other long-term assets)2
After Adjustment
Adjusted total assets

Based on: 10-K (reporting date: 2023-12-31), 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31).

1 Operating lease right-of-use asset (before adoption of FASB Topic 842). See details »

2 Deferred income tax assets (classified as Other long-term assets). See details »


The data reveals an overall upward trend in both total assets and adjusted total assets over the five-year period from 2019 to 2023. Total assets increased from 29,074 million US dollars in 2019 to 47,065 million US dollars in 2023, representing substantial growth with a peak in 2021 at 44,358 million US dollars, followed by a slight decrease in 2022 before rising again in 2023.

Adjusted total assets, which closely mirror total assets, follow a similar trajectory, starting at 29,143 million US dollars in 2019 and increasing steadily to 47,105 million US dollars by 2023. The pattern also shows a peak in 2021 at 44,441 million US dollars, a modest dip in 2022 to 43,125 million US dollars, and a subsequent increase in 2023.

Trend Analysis:
Both total and adjusted total assets exhibit consistent growth over the five years, indicating expansion in the asset base.
Year-to-Year Changes:
From 2019 to 2020, there is a significant jump in asset values, which continues into 2021. The slight reduction observed in 2022 may suggest a period of consolidation or revaluation. The rebound in 2023 points towards resumed asset growth or acquisition activity.
Comparison Between Total Assets and Adjusted Total Assets:
The close alignment of total and adjusted total assets indicates limited adjustments between the two figures, suggesting that the adjustments applied have a minimal impact on the overall asset valuation.

Overall, the data indicates a healthy growth trajectory in the company's asset base, with minor fluctuations that require monitoring but do not undermine the general positive trend observed across the analyzed period.


Adjustments to Current Liabilities

Humana Inc., adjusted current liabilities

US$ in millions

Microsoft Excel
Dec 31, 2023 Dec 31, 2022 Dec 31, 2021 Dec 31, 2020 Dec 31, 2019
As Reported
Current liabilities
Adjustments
Less: Current unearned revenues
After Adjustment
Adjusted current liabilities

Based on: 10-K (reporting date: 2023-12-31), 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31).


The analysis of the annual data for current liabilities and adjusted current liabilities of the company reveals consistent growth over the five-year period under review.

Current Liabilities
The current liabilities increased steadily from US$10,929 million in 2019 to US$18,872 million in 2023. This represents a significant rise, indicating a growing amount of obligations due within one year. The year-over-year increases reflect a continuous upward trend without any reversals or plateaus, suggesting escalating short-term financial responsibilities.
Adjusted Current Liabilities
Similarly, the adjusted current liabilities follow the same upward trajectory, rising from US$10,682 million in 2019 to US$18,606 million in 2023. The adjusted figures are consistently slightly lower than the nominal current liabilities, which implies the adjustments made remove certain components, but both metrics display parallel increases each year.
Trend Insights
The persistent growth in both current and adjusted current liabilities may imply increased operational scale or possibly rising short-term financing or payables. This pattern could suggest the company is either expanding its activities or its short-term obligations are escalating. Without data on current assets or liquidity ratios, the impact on financial stability is indeterminate, but the consistent increase in liabilities highlights a need for monitoring working capital management closely.

Adjustments to Total Liabilities

Humana Inc., adjusted total liabilities

US$ in millions

Microsoft Excel
Dec 31, 2023 Dec 31, 2022 Dec 31, 2021 Dec 31, 2020 Dec 31, 2019
As Reported
Total liabilities
Adjustments
Add: Operating lease liability (before adoption of FASB Topic 842)1
Less: Deferred income tax liabilities (classified as Other long-term liabilities)2
Less: Unearned revenues
After Adjustment
Adjusted total liabilities

Based on: 10-K (reporting date: 2023-12-31), 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31).

1 Operating lease liability (before adoption of FASB Topic 842). See details »

2 Deferred income tax liabilities (classified as Other long-term liabilities). See details »


The financial data reveals a consistent upward trend in the company's total liabilities over the five-year period from 2019 through 2023. Specifically, total liabilities increased from 17,037 million US dollars in 2019 to 30,747 million US dollars in 2023, indicating a substantial growth in the company's obligations.

Adjusted total liabilities, which likely account for some form of reclassification or exclusion of certain liabilities, follow a similar pattern to the total liabilities. These liabilities rose from 16,449 million US dollars in 2019 to 30,481 million US dollars in 2023. The adjusted figures closely track the total liabilities, suggesting consistency between the reported and adjusted measures of obligations.

Year-over-Year Growth
Between 2019 and 2020, total liabilities increased by approximately 24.7%, reflecting a significant jump within a one-year period. This growth continued through the following years, though at varying rates. The increase from 2020 to 2021 was around 33%, the largest within the period, indicating accelerated accumulation of liabilities. A slight decrease occurred in 2022, with total liabilities marginally declining by about 2.5% compared to 2021. However, the upward trend resumed in 2023 with a 11% increase.
Adjusted Liabilities Trend
The adjusted total liabilities mirrored the overall trend with increases in four out of five years. From 2019 to 2020, the adjusted liabilities rose by approximately 23%. The increase continued robustly from 2020 to 2021, at nearly 35%. In 2022, these adjusted figures showed a minor decrease of approximately 0.11%, indicating some stabilization or adjustment. By 2023, adjusted liabilities again climbed by 11.3%, consistent with the total liabilities pattern.
Comparative Analysis
The small difference between total and adjusted liabilities each year indicates that adjustments represent a relatively minor component of overall liabilities. The slight discrepancy narrowed over time, suggesting possible changes in accounting practices or adjustments becoming less significant relative to total liabilities.

Overall, the data demonstrates a clear and substantial increase in the company's liabilities over the five years, punctuated by a brief stabilization in 2022. This trend reflects increasing financial commitments, which may have implications for liquidity, leverage, and risk management strategies going forward.


Adjustments to Stockholders’ Equity

Humana Inc., adjusted stockholders’ equity

US$ in millions

Microsoft Excel
Dec 31, 2023 Dec 31, 2022 Dec 31, 2021 Dec 31, 2020 Dec 31, 2019
As Reported
Stockholders’ equity
Adjustments
Less: Net deferred income tax assets (liabilities)1
Add: Allowance for doubtful accounts
Add: Unearned revenues
Add: Noncontrolling interests
After Adjustment
Adjusted total equity

Based on: 10-K (reporting date: 2023-12-31), 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31).

1 Net deferred income tax assets (liabilities). See details »


The analysis of the provided financial data reveals certain trends in the equity positions over the five-year period from December 31, 2019, through December 31, 2023.

Stockholders’ Equity

This metric shows a generally increasing trend over the observed period. Beginning at approximately 12,037 million US dollars at the end of 2019, stockholders’ equity rose to 13,728 million by the end of 2020, marking significant growth. The upward trajectory continued to reach 16,080 million in 2021. However, the figure decreased to 15,311 million in 2022, indicating a temporary decline. By the end of 2023, stockholders’ equity recovered moderately to 16,262 million. Overall, despite the dip in 2022, the equity position exhibits positive growth across the five years.

Adjusted Total Equity

This measure, which presumably accounts for certain adjustments beyond basic stockholders’ equity, also exhibited a predominantly rising trend. It started at 12,694 million US dollars in 2019, increased significantly to 14,777 million in 2020, and further advanced to 17,138 million in 2021. A decline occurred in 2022, with adjusted total equity dropping to 15,753 million. By the end of 2023, the figure increased again to 16,624 million. This trend closely mirrors that of stockholders’ equity, showing robust growth overall with a notable downturn in 2022 followed by partial recovery.

In summary, both stockholders’ equity and adjusted total equity have generally strengthened over the five-year period, reflecting an increase in the company's net worth. The year 2022 marks a point of contraction in both measures, which could warrant further investigation into the underlying causes. Nevertheless, the recovery observed in 2023 suggests resilience and a return toward prior growth levels.


Adjustments to Capitalization Table

Humana Inc., adjusted capitalization table

US$ in millions

Microsoft Excel
Dec 31, 2023 Dec 31, 2022 Dec 31, 2021 Dec 31, 2020 Dec 31, 2019
As Reported
Book overdraft
Short-term debt
Long-term debt
Total reported debt
Stockholders’ equity
Total reported capital
Adjustments to Debt
Add: Operating lease liability (before adoption of FASB Topic 842)1
Add: Operating lease liabilities (included within Trade accounts payable and accrued expenses)2
Add: Operating lease liabilities (included within Other long-term liabilities)3
Adjusted total debt
Adjustments to Equity
Less: Net deferred income tax assets (liabilities)4
Add: Allowance for doubtful accounts
Add: Unearned revenues
Add: Noncontrolling interests
Adjusted total equity
After Adjustment
Adjusted total capital

Based on: 10-K (reporting date: 2023-12-31), 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31).

1 Operating lease liability (before adoption of FASB Topic 842). See details »

2 Operating lease liabilities (included within Trade accounts payable and accrued expenses). See details »

3 Operating lease liabilities (included within Other long-term liabilities). See details »

4 Net deferred income tax assets (liabilities). See details »


The financial data reveals notable trends in the capital structure of the company over the five-year period ending in 2023.

Total Reported Debt
The total reported debt increased significantly from 5,891 million USD in 2019 to 12,820 million USD in 2021, more than doubling in two years. This peak was followed by a slight reduction in 2022 to 11,424 million USD before rising again to 12,009 million USD in 2023. Overall, the debt level shows a pattern of rapid growth followed by minor fluctuations.
Stockholders’ Equity
Stockholders' equity displayed a consistent upward trend, growing from 12,037 million USD in 2019 to 16,262 million USD in 2023. There was a slight decline in 2022 to 15,311 million USD, but the overall trajectory remained positive, indicating strengthening equity base over the years.
Total Reported Capital
This metric, reflecting the sum of debt and equity, rose markedly from 17,928 million USD in 2019 to a peak of 28,900 million USD in 2021. After a decrease in 2022 to 26,735 million USD, it increased again to 28,271 million USD in 2023. The trend mirrors the movements in debt and equity, reflecting expansion in total capital resources with some moderation in 2022.
Adjusted Total Debt
Adjusted total debt followed a pattern similar to reported debt, rising from 6,339 million USD in 2019 to 13,551 million USD in 2021, then decreasing to 12,032 million USD in 2022, before climbing to 12,602 million USD in 2023. The adjustments appear to reinforce the general movement seen in reported debt figures.
Adjusted Total Equity
Adjusted equity also showed growth from 12,694 million USD in 2019 to 17,138 million USD in 2021, dipped to 15,753 million USD in 2022, and then rose again to 16,624 million USD in 2023. This closely aligns with the trend in reported stockholders’ equity, suggesting consistent underlying equity strength.
Adjusted Total Capital
The adjusted total capital increased substantially from 19,033 million USD in 2019 to 30,689 million USD in 2021, followed by a reduction to 27,785 million USD in 2022, and a subsequent rise to 29,226 million USD in 2023. This trend reflects the combined movements of adjusted debt and equity, highlighting an overall expansion with a slight contraction in 2022.

In summary, the data shows that the company substantially increased both its debt and equity levels up to 2021, indicating aggressive capital accumulation or expansion during this period. A noticeable but temporary decline occurred in 2022 across most metrics, suggesting some deleveraging or capital readjustment. By 2023, the company appeared to resume growth in both debt and equity, maintaining a strong capital base. These patterns imply active management of capital structure with a tendency toward growth and occasional recalibration.


Adjustments to Revenues

Humana Inc., adjusted external revenues

US$ in millions

Microsoft Excel
12 months ended: Dec 31, 2023 Dec 31, 2022 Dec 31, 2021 Dec 31, 2020 Dec 31, 2019
As Reported
External revenues
Adjustment
Add: Increase (decrease) in unearned revenues
After Adjustment
Adjusted external revenues

Based on: 10-K (reporting date: 2023-12-31), 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31).


The financial data reveals a consistent upward trend in both external revenues and adjusted external revenues over the five-year period ending December 31, 2023.

External Revenues
The external revenues exhibit steady growth from US$64,387 million in 2019 to US$105,305 million in 2023. This corresponds to a compounded increase of approximately 10% per annum. The year-over-year increases are gradual and consistent, indicating a positive trajectory in the company's revenue-generating capacity.
Adjusted External Revenues
Adjusted external revenues follow a near-identical pattern to external revenues, increasing from US$64,351 million in 2019 to US$105,285 million in 2023. The small discrepancies between external revenues and adjusted external revenues are minimal, suggesting limited adjustments and confirming the robustness of reported revenue figures.

Overall, the data indicates strong and steady financial performance with continuous revenue growth over the analyzed timeframe. This consistent upward movement in revenues suggests effective business operations and a successful market presence throughout the period.


Adjustments to Reported Income

Humana Inc., adjusted net income attributable to Humana

US$ in millions

Microsoft Excel
12 months ended: Dec 31, 2023 Dec 31, 2022 Dec 31, 2021 Dec 31, 2020 Dec 31, 2019
As Reported
Net income attributable to Humana
Adjustments
Add: Deferred income tax expense (benefit)1
Add: Increase (decrease) in allowance for doubtful accounts
Add: Increase (decrease) in unearned revenues
Add: Other comprehensive income (loss), net of tax
Add: Comprehensive income (loss), net of tax, attributable to noncontrolling interest
After Adjustment
Adjusted net income

Based on: 10-K (reporting date: 2023-12-31), 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31).

1 Deferred income tax expense (benefit). See details »


The financial data over the five-year period ending in 2023 reflects noticeable fluctuations in both net income attributable to Humana and adjusted net income.

Net Income Attributable to Humana
The net income showed an upward trend from 2019 to 2020, increasing from 2,707 million US dollars to 3,367 million US dollars. However, it then experienced a decline in the following years, dropping to 2,933 million in 2021, 2,806 million in 2022, and further down to 2,489 million in 2023. This indicates a reversal of the initial growth observed between 2019 and 2020, with a consistent downward trend from 2021 onward.
Adjusted Net Income
The adjusted net income follows a somewhat different pattern. It increased from 3,138 million in 2019 to 3,871 million in 2020, representing a strong growth year. However, a significant decrease occurred in 2021 and 2022, where the adjusted net income fell sharply to 2,547 million and then further to 1,375 million respectively. In 2023, the adjusted net income rebounded to 2,623 million, indicating a partial recovery but still remaining below the peak levels seen in 2019 and 2020.

Overall, the data shows that while the company experienced growth in net income and adjusted net income up to 2020, both metrics showed declines thereafter, with net income exhibiting a gradual decrease and adjusted net income showing a more pronounced volatility and sharp drop before recovering partially in the most recent year. The disparity in the trends between net income and adjusted net income in the later years suggests possible changes in adjustments applied or operational factors impacting the adjusted figures differently.